Tomas Leanderson (Former)
41 – 50 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria
(
- Contribution to journal › Article
- 2006
-
Mark
CArG box-binding factor-A interacts with multiple motifs in immunoglobulin promoters and has a regulated subcellular distribution.
(
- Contribution to journal › Article
-
Mark
Joining-chain (J-chain) negative mice are B cell memory deficient.
(
- Contribution to journal › Article
-
Mark
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
(
- Contribution to journal › Article
-
Mark
SPI-C and STAT6 can cooperate to stimulate IgE germline transcription.
(
- Contribution to journal › Article
-
Mark
The kappa promoter penta-decamer binding protein CBF-A interacts specifically with nucleophosmin in the nucleus only.
(
- Contribution to journal › Article
- 2005
-
Mark
Quinic acid is a biologically active component of the Uncaria tomentosa extract C-Med 100(R).
(
- Contribution to journal › Article
- 2004
-
Mark
Identification of a novel thioredoxin-related protein, PC-TRP, which is preferentially expressed in plasma cells.
(
- Contribution to journal › Article
-
Mark
Frequent activation of CArG binding factor-A expression and binding in N-methyl-N-nitrosourea-induced rat mammary carcinomas
(
- Contribution to journal › Article
- 2003
-
Mark
An extract of Uncaria tomentosa inhibiting cell division and NF-kappaB activity without inducing cell death.
(
- Contribution to journal › Article